Epsilogen (formerly IGEM Therapeutics) is an immuno-oncology company specializing in the development of IgE antibody drugs to fight cancer. It is focused on the engineering structural variants of IgE that kill parasites residing in human tissue. The company also develops an antibody platform technology based on protein and glycoengineering of the epsilon constant region.